These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38734079)

  • 1. Follow-up biopsies in gastrointestinal immune checkpoint inhibitor toxicity may show markedly different inflammatory patterns than initial injury.
    Tomm NK; Szczepanski JM; Fang JM; Choi WT; Xue Y; Setia N; Karamchandani DM; Cheng JY; Westerhoff M
    Hum Pathol; 2024 Jun; 148():60-65. PubMed ID: 38734079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
    Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
    Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-specific variations in morphological patterns of injury in immune check-point inhibitor-associated colitis.
    Isidro RA; Ruan AB; Gannarapu S; Raj D; Rahma O; Grover S; Srivastava A
    Histopathology; 2021 Mar; 78(4):532-541. PubMed ID: 32931028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis.
    Mooradian MJ; Wang DY; Coromilas A; Lumish M; Chen T; Giobbie-Hurder A; Johnson DB; Sullivan RJ; Dougan M
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.
    Lenti MV; Ribaldone DG; Borrelli de Andreis F; Vernero M; Barberio B; De Ruvo M; Savarino EV; Kav T; Blesl A; Franzoi M; Gröchenig HP; Pugliese D; Ianiro G; Porcari S; Cammarota G; Gasbarrini A; Spagnuolo R; Ellul P; Foteinogiannopoulou K; Koutroubakis I; Argyriou K; Cappello M; Jauregui-Amezaga A; Demarzo MG; Silvestris N; Armuzzi A; Sottotetti F; Bertani L; Festa S; Eder P; Pedrazzoli P; Lasagna A; Vanoli A; Gambini G; Santacroce G; Rossi CM; Delliponti M; Klersy C; Corazza GR; Di Sabatino A;
    ESMO Open; 2024 Jul; 9(7):103632. PubMed ID: 38970840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.
    Hone Lopez S; Kats-Ugurlu G; Renken RJ; Buikema HJ; de Groot MR; Visschedijk MC; Dijkstra G; Jalving M; de Haan JJ
    Virchows Arch; 2021 Dec; 479(6):1119-1129. PubMed ID: 34338882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma.
    Yin J; Elias R; Peng L; Levonyak N; Asokan A; Christie A; Kubiliun N; Brugarolas J; Hammers HJ
    Clin Genitourin Cancer; 2022 Jun; 20(3):260-269. PubMed ID: 35277350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy.
    Lo YC; Price C; Blenman K; Patil P; Zhang X; Robert ME
    Am J Clin Pathol; 2021 Jul; 156(2):214-228. PubMed ID: 33555016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study.
    Sleiman J; Wei W; Shah R; Faisal MS; Philpott J; Funchain P
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating Posttransplant Inflammatory Bowel Disease and Other Colitides in Renal Transplant Patients.
    Pittman ME; Jessurun J; Yantiss RK
    Am J Surg Pathol; 2017 Dec; 41(12):1666-1674. PubMed ID: 28786879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-Gamma-Producing CD8
    Sasson SC; Slevin SM; Cheung VTF; Nassiri I; Olsson-Brown A; Fryer E; Ferreira RC; Trzupek D; Gupta T; Al-Hillawi L; Issaias ML; Easton A; Campo L; FitzPatrick MEB; Adams J; Chitnis M; Protheroe A; Tuthill M; Coupe N; Simmons A; Payne M; Middleton MR; Travis SPL; ; Fairfax BP; Klenerman P; Brain O
    Gastroenterology; 2021 Oct; 161(4):1229-1244.e9. PubMed ID: 34147519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnifying endoscopy with crystal violet staining for immune checkpoint inhibitor-associated colitis.
    Inoue S; Kono M; Fukuda H; Shimamoto Y; Nakagawa K; Ohmori M; Iwagami H; Matsuno K; Iwatsubo T; Nakahira H; Matsuura N; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Kitamura M; Nakatsuka S; Kunimasa K; Kumagai T; Isei T; Ishihara R
    J Gastroenterol Hepatol; 2021 May; 36(5):1180-1186. PubMed ID: 32888202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P067 Immune Checkpoint Inhibitor Colitis in a Community-Based Hospital System.
    Rampersad A; Abrams G; Bauer C
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S17-S18. PubMed ID: 37461984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID.
    Amiot A; Laharie D; Malamut G; Serrero M; Poullenot F;
    Dig Liver Dis; 2022 Sep; 54(9):1162-1167. PubMed ID: 35842365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-detector computed tomography (MDCT)-based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis.
    Pisuchpen N; Durbin SM; Mooradian MJ; Fintelmann FJ; Reynolds KL; Dougan M; Kambadakone A
    Eur Radiol; 2021 Dec; 31(12):8868-8878. PubMed ID: 34081152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Adverse Events Induced by Immune-Checkpoint Inhibitors.
    Yanai S; Toya Y; Sugai T; Matsumoto T
    Digestion; 2021; 102(6):965-973. PubMed ID: 34515105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitor-induced diarrhea: Clinicopathological study of 11 patients.
    Yanai S; Nakamura S; Kawasaki K; Toya Y; Akasaka R; Oizumi T; Ishida K; Sugai T; Matsumoto T
    Dig Endosc; 2020 May; 32(4):616-620. PubMed ID: 31595568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of incidental chronic colitis: a study of 17 cases.
    Deshpande V; Hsu M; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2010 Apr; 34(4):463-9. PubMed ID: 20154590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Checkpoint Inhibitor-associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies.
    Tran AN; Wang M; Hundt M; Chugh R; Ohm J; Grimshaw A; Ciarleglio M; Hung KW; Proctor DD; Price CC; Laine L; Al-Bawardy B
    J Immunother; 2021 Oct; 44(8):325-334. PubMed ID: 34380976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalamine and cholestyramine for immune checkpoint inhibitor-mediated diarrhea and colitis.
    Hollander B; Khurana S; Jacob JS; Altan M; Wang J; Zhao D; Varatharajalu K; Alasadi M; Thomas AS; Wang Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3637-3648. PubMed ID: 35972690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.